Endocannabinoids Mediate Presynaptic Inhibition of Glutamatergic Transmission in Rat Ventral Tegmental Area Dopamine Neurons through Activation of CB1 Receptors
Open accessThe DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Abstract
The endogenous cannabinoid system has been shown to play a crucial role in controlling neuronal excitability and synaptic transmission. In this study we investigated the effects of a cannabinoid receptor (CB-R) agonist WIN 55,212-2 (WIN) on excitatory synaptic transmission in the rat ventral tegmental area (VTA). Whole-cell patch clamp recordings were performed from VTA dopamine (DA) neurons in an in vitro slice preparation. WIN reduced both NMDA and AMPA EPSCs, as well as miniature EPSCs (mEPSCs), and increased the paired-pulse ratio, indicating a presynaptic locus of its action. We also found that WIN-induced effects were dose-dependent and mimicked by the CB1-R agonist HU210. Furthermore, two CB1-R antagonists, AM281 and SR141716A, blocked WIN-induced effects, suggesting that WIN modulates excitatory synaptic transmission via activation of CB1-Rs. Our additional finding that both AM281 and SR141716A per se increased NMDA EPSCs suggests that endogenous cannabinoids, released from depolarized postsynaptic neurons, might act retrogradely on presynaptic CB1-Rs to suppress glutamate release. Hence, we report that a type of synaptic modulation, previously termed depolarization-induced suppression of excitation (DSE), is present also in the VTA as a calcium-dependent phenomenon, blocked by both AM281 and SR141716A, and occluded by WIN. Importantly, DSE was partially blocked by the D 2 DA antagonist eticlopride and enhanced by the D 2 DA agonist quinpirole without changing the presynaptic cannabinoid sensitivity. These results indicate that the two pathways work in a cooperative manner to release endocannabinoids in the VTA, where they play a role as retrograde messengers for DSE via CB1-Rs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Predictive reward signal of dopamine neurons
Schultz, W. (1998) · Journal of Neurophysiology · doi:10.1152/jn.1998.80.1.1 · Cited by 4,564
Paxinos, G. (1985) · Cited by 3,715
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913 · cited 1×
“, 1992) and 2-arachidonylglycerol (2AG) (Mechoulam et al., 1995; Sugiura et al., 1995, 1999), which are produced and released from neurons (Di Marzo et al.”
Background2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196
Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
Zygmunt, P. M., Petersson, J., Andersson, D. A., Chuang, H.-H., Sørgård, M., Di Marzo, V., Julius, D., & Högestätt, E. D. (1999) · Nature · doi:10.1038/22761 · Cited by 2,142 · cited 13×
“, January 7 NMDA EPSCs , and CPZ by itself inhibits NMDA EPSCs , indicate a tonic role of VR1 in facilitating , rather than inhibiting , excita - tory transmission in the midbrain ( Marinelli et al .”
BackgroundResultInfluentialGrace, A. A. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90196-u · Cited by 1,831
Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses
Wilson, R. I., & Nicoll, R. A. (2001) · Nature · doi:10.1038/35069076 · Cited by 1,607 · cited 2×
“Eventually, this phenomenon could be ascribed to endocannabinoids produced and released from depolarized postsynaptic DA neurons, as described in other brain regions (Kreitzer and Regehr, 2001; Maejima et al., 2001; Ohno-Shosaku et al., 2001; Wilson and Nicoll, 2001; Wilson et al., 2001; Kreitzer et al., 2002; Ohno-Sh…”
BackgroundA second endogenous cannabinoid that modulates long-term potentiation
Stella, N., Schweitzer, P., & Piomelli, D. (1997) · Nature · doi:10.1038/42015 · Cited by 1,496
Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons
Ungless, M. A., Whistler, J. L., Malenka, R. C., & Bonci, A. (2001) · Nature · doi:10.1038/35079077 · Cited by 1,106
Wise, R. A. (1996) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(96)80079-1 · Cited by 1,072
Kreitzer, A. C., & Regehr, W. G. (2001) · Neuron · doi:10.1016/s0896-6273(01)00246-x · Cited by 875
Ohno-Shosaku, T., Maejima, T., & Kano, M. (2001) · Neuron · doi:10.1016/s0896-6273(01)00247-1 · Cited by 845
Sesack, S. R., & Pickel, V. M. (1992) · Journal of Comparative Neurology · doi:10.1002/cne.903200202 · Cited by 820
Functional Role of High-Affinity Anandamide Transport, as Revealed by Selective Inhibition
Beltramo, M., Stella, N., Calignano, A., Lin, S. Y., Makriyannis, A., & Piomelli, D. (1997) · Science · doi:10.1126/science.277.5329.1094 · Cited by 813
The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)
Smart, D., Gunthorpe, M. J., Jerman, J. C., Nasir, S., Gray, J., Muir, A. I., Chambers, J. K., Randall, A. D., & Davis, J. B. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703050 · Cited by 775
Postsynaptic endocannabinoid release is critical to long-term depression in the striatum
Gerdeman, G. L., Ronesi, J., & Lovinger, D. M. (2002) · Nature Neuroscience · doi:10.1038/nn832 · Cited by 767
Dopamine neurons and their role in reward mechanisms
Schultz, W. (1997) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(97)80007-4 · Cited by 766
Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action
Di Marzo, V., Melck, D., Bisogno, T., & De Petrocellis, L. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01283-1 · Cited by 712
Two types of neurone in the rat ventral tegmental area and their synaptic inputs.
Johnson, S. W., & North, R. A. (1992) · The Journal of Physiology · doi:10.1113/jphysiol.1992.sp019136 · Cited by 669
Localization of cannabinoid receptor mRNA in rat brain
Matsuda, L. A., Bonner, T. I., & Lolait, S. J. (1993) · Journal of Comparative Neurology · doi:10.1002/cne.903270406 · Cited by 631 · cited 2×
“In support with this hypothesis, CB1-R mRNA has been found in those brain regions that send glutamatergic afferents to the VTA, such as prefrontal cortex, subthalamic nucleus, pedunculopontine nucleus, and amygdala (Matsuda et al., 1993).”
BackgroundDebanne, D., Guérineau, N. C., Gähwiler, B. H., & Thompson, S. M. (1996) · The Journal of Physiology · doi:10.1113/jphysiol.1996.sp021204 · Cited by 614
Shen, M., Piser, T. M., Seybold, V. S., & Thayer, S. A. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-14-04322.1996 · Cited by 604
Maejima, T., Hashimoto, K., Yoshida, T., Aiba, A., & Kano, M. (2001) · Neuron · doi:10.1016/s0896-6273(01)00375-0 · Cited by 555
Presynaptic Specificity of Endocannabinoid Signaling in the Hippocampus
Wilson, R. I., Kunos, G., & Nicoll, R. A. (2001) · Neuron · doi:10.1016/s0896-6273(01)00372-5 · Cited by 544
Neuronal localization of cannabinoid receptors in the basal ganglia of the rat
Herkenham, M., Lynn, A. B., de Costa, B. R., & Richfield, E. K. (1991) · Brain Research · doi:10.1016/0006-8993(91)90970-7 · Cited by 515
Burst firing in midbrain dopaminergic neurons
Overton, P. G., & Clark, D. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00039-8 · Cited by 466
Cyclic AMP Mediates a Presynaptic Form of LTP at Cerebellar Parallel Fiber Synapses
Salin, P. A., Malenka, R. C., & Nicoll, R. A. (1996) · Neuron · doi:10.1016/s0896-6273(00)80099-9 · Cited by 437
The endocannabinoid system as a target for therapeutic drugs
Piomelli, D., Giuffrida, A., Calignano, A., & Rodrı́guez de Fonseca, F. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01482-6 · Cited by 421
Burst Firing in Dopamine Neurons Induced by N -Methyl-D-aspartate: Role of Electrogenic Sodium Pump
Johnson, S. W., Seutin, V., & North, R. A. (1992) · Science · doi:10.1126/science.1329209 · Cited by 419
Metabotropic Glutamate Receptors Drive the Endocannabinoid System in Hippocampus
Varma, N., Carlson, G. C., Ledent, C., & Alger, B. E. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-24-j0003.2001 · Cited by 406
CANNABINOID RECEPTORS AND THEIR ENDOGENOUS AGONISTS
Felder, C. C., & Glass, M. (1998) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.179 · Cited by 390
Murase, S., Grenhoff, J., Chouvet, G., Gonon, F. G., & Svensson, T. H. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90641-w · Cited by 387
Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors
Gessa, G., Melis, M., Muntoni, A., & Diana, M. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01442-8 · Cited by 370
Self-citationDe Petrocellis, L., Bisogno, T., Maccarrone, M., Davis, J. B., Finazzi-Agrò, A., & Di Marzo, V. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008555200 · Cited by 355
Anandamide Induces Apoptosis in Human Cells via Vanilloid Receptors
Maccarrone, M., Lorenzon, T., Bari, M., Melino, G., & Finazzi-Agrò, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005722200 · Cited by 347
Bonci, A., & Malenka, R. C. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-10-03723.1999 · Cited by 317
Evidence That the Cannabinoid CB1 Receptor Is a 2-Arachidonoylglycerol Receptor
Sugiura, T., Kodaka, T., Nakane, S., Miyashita, T., Kondo, S., Suhara, Y., Takayama, H., Waku, K., Seki, C., Baba, N., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.5.2794 · Cited by 310
di Marzo, V., Hill, M. P., Bisogno, T., Crossman, A. R., & Brotchie, J. M. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.10.1432 · Cited by 303
Ohno-Shosaku, T., Tsubokawa, H., Mizushima, I., Yoneda, N., Zimmer, A., & Kano, M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-10-03864.2002 · Cited by 301
Ungless, M. A., Singh, V., Crowder, T. L., Yaka, R., Ron, D., & Bonci, A. (2003) · Neuron · doi:10.1016/s0896-6273(03)00461-6 · Cited by 297
Auclair, N., Otani, S., Soubrie, P., & Crepel, F. (2000) · Journal of Neurophysiology · doi:10.1152/jn.2000.83.6.3287 · Cited by 290
Increased probability of GABA release during withdrawal from morphine
Bonci, A., & Williams, J. T. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-02-00796.1997 · Cited by 286 · cited 1×
“…affect the paired-pulse ratio in several brain regions (Mennerick and Zorumski, 1995; Debanne et al., 1996; Salin et al., 1996), including the VTA (Bonci and Williams, 1997; Manzoni and Williams, 1999; Melis et al., 2002), these results suggest that WIN might reduce glutamate release at a…”
BackgroundGariano, R. F., & Groves, P. M. (1988) · Brain Research · doi:10.1016/0006-8993(88)90606-3 · Cited by 286
Transient changes in mesolimbic dopamine and their association with ‘reward’
Wightman, R. M., & Robinson, D. L. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01005.x · Cited by 281
Szabo, B., Siemes, S., & Wallmichrath, I. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02041.x · Cited by 277
Structural determinants for recognition and translocation by the anandamide transporter
Piomelli, D., Beltramo, M., Glasnapp, S., Lin, S. Y., Goutopoulos, A., Xie, X.-Q., & Makriyannis, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5802 · Cited by 268
Marinelli, S., Di Marzo, V., Berretta, N., Matias, I., Maccarrone, M., Bernardi, G., & Mercuri, N. B. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-08-03136.2003 · Cited by 258
Cortical Regulation of Subcortical Dopamine Release: Mediation via the Ventral Tegmental Area
Taber, M. T., Das, S., & Fibiger, H. C. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65031407.x · Cited by 253
Huang, C., Lo, S., & Hsu, K. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.0731e.x · Cited by 248
Ryu, S. H., Cho, K. S., Lee, K. Y., Suh, P. G., & Rhee, S. G. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45235-0 · Cited by 242
Vaughan, C. W., Connor, M., Bagley, E. E., & Christie, M. J. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23200-4 · Cited by 241
Ross, R. A., Gibson, T. M., Brockie, H. C., Leslie, M., Pashmi, G., Craib, S. J., Di Marzo, V., & Pertwee, R. G. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703850 · Cited by 237 · cited 11×
“However, several investigators have provided evidence that anandamide, at concentrations similar or higher than those required to activate CB1-Rs, also functions as an agonist at VR1 (Zygmunt et al., 1999; Maccarrone et al., 2000; Smart et al., 2000; Ross et al., 2001).”
BackgroundInfluentialFrench, E. D. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00278-4 · Cited by 236
Brown, S. P., Brenowitz, S. D., & Regehr, W. G. (2003) · Nature Neuroscience · doi:10.1038/nn1126 · Cited by 234
Reversal of Dopamine D2Receptor Responses by an Anandamide Transport Inhibitor
Beltramo, M., de Fonseca, F. R., Navarro, M., Calignano, A., Gorriti, M. A., Grammatikopoulos, G., Sadile, A. G., Giuffrida, A., & Piomelli, D. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-09-03401.2000 · Cited by 232
Beltramo, M., & Piomelli, D. (2000) · NeuroReport · doi:10.1097/00001756-200004270-00018 · Cited by 230
Christie, M. J., Bridge, S., James, L. B., & Beart, P. M. (1985) · Brain Research · doi:10.1016/0006-8993(85)90140-4 · Cited by 228
Azad, S. C., Eder, M., Marsicano, G., Lutz, B., Zieglgänsberger, W., & Rammes, G. (2003) · Learning & Memory · doi:10.1101/lm.53303 · Cited by 220
Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum
Szabo, B., Dörner, L., Pfreundtner, C., Nörenberg, W., & Starke, K. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00597-6 · Cited by 217
Modulation of Long-Term Depression by Dopamine in the Mesolimbic System
Thomas, M. J., Malenka, R. C., & Bonci, A. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-15-05581.2000 · Cited by 212
The Cellular Uptake of Anandamide Is Coupled to Its Breakdown by Fatty-acid Amide Hydrolase
Deutsch, D. G., Glaser, S. T., Howell, J. M., Kunz, J. S., Puffenbarger, R. A., Hillard, C. J., & Abumrad, N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m003161200 · Cited by 206
Long-Term Plasticity of Endocannabinoid Signaling Induced by Developmental Febrile Seizures
Chen, K., Ratzliff, A., Hilgenberg, L., Gulyás, A., Freund, T. F., Smith, M., Dinh, T. P., Piomelli, D., Mackie, K., & Soltesz, I. (2003) · Neuron · doi:10.1016/s0896-6273(03)00499-9 · Cited by 204
Jaffe, E. H., Marty, A., Schulte, A., & Chow, R. H. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-10-03548.1998 · Cited by 199
Melis, M., Camarini, R., Ungless, M. A., & Bonci, A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-06-02074.2002 · Cited by 196 · cited 1×
“…paired-pulse ratio in several brain regions (Mennerick and Zorumski, 1995; Debanne et al., 1996; Salin et al., 1996), including the VTA (Bonci and Williams, 1997; Manzoni and Williams, 1999; Melis et al., 2002), these results suggest that WIN might reduce glutamate release at a presynaptic site.”
ResultSelf-citationQuantal Mechanism of Neural Transmitter Release
Katz, B. (1971) · Science · doi:10.1126/science.173.3992.123 · Cited by 194
Ohno‐Shosaku, T., Shosaku, J., Tsubokawa, H., & Kano, M. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.01929.x · Cited by 179
Rice, M. E., Cragg, S. J., & Greenfield, S. A. (1997) · Journal of Neurophysiology · doi:10.1152/jn.1997.77.2.853 · Cited by 173
Mennerick, S., & Zorumski, C. F. (1995) · The Journal of Physiology · doi:10.1113/jphysiol.1995.sp020948 · Cited by 171
Inhibition of Interneuron Firing Extends the Spread of Endocannabinoid Signaling in the Cerebellum
Kreitzer, A. C., Carter, A. G., & Regehr, W. G. (2002) · Neuron · doi:10.1016/s0896-6273(02)00695-5 · Cited by 167
Ohno‐Shosaku, T., Matsui, M., Fukudome, Y., Shosaku, J., Tsubokawa, H., Taketo, M. M., Manabe, T., & Kano, M. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02732.x · Cited by 166
Presynaptic Regulation of Glutamate Release in the Ventral Tegmental Area During Morphine Withdrawal
Manzoni, O. J., & Williams, J. T. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-15-06629.1999 · Cited by 162
Svensson, T. H., & TUNG, C. ‐. (1989) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1989.tb08640.x · Cited by 155
Cannabinoids inhibit excitatory neurotransmission in the substantia nigra pars reticulata
Szabó, B., Wallmichrath, I., Mathonia, P., & Pfreundtner, C. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00036-1 · Cited by 140
Gatley, S. J., Lan, R., Volkow, N. D., Pappas, N., King, P., Wong, C. T., Gifford, A. N., Pyatt, B., Dewey, S. L., & Makriyannis, A. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70010417.x · Cited by 123
Anandamide: an endogenous activator of the vanilloid receptor
Smart, D., & Jerman, J. C. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01459-0 · Cited by 120
Jones, S., & Kauer, J. A. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-22-09780.1999 · Cited by 118
Trettel, J., & Levine, E. S. (2003) · Journal of Neurophysiology · doi:10.1152/jn.01037.2002 · Cited by 117
Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices
Ameri, A., Wilhelm, A., & Simmet, T. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702478 · Cited by 117
Calcium Dependence of Retrograde Inhibition by Endocannabinoids at Synapses onto Purkinje Cells
Brenowitz, S. D., & Regehr, W. G. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-15-06373.2003 · Cited by 116
Grillner, P., & Mercuri, N. B. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00418-1 · Cited by 110
Okubo, Y., Kakizawa, S., Hirose, K., & Iino, M. (2001) · Neuron · doi:10.1016/s0896-6273(01)00464-0 · Cited by 110
Mechoulam, R., Fride, E., Ben‐Shabat, S., Meiri, U., & Horowitz, M. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00777-8 · Cited by 107
Romero, J., Hillard, C. J., Calero, M., & Rábano, A. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00167-5 · Cited by 85
Neuromorphological background of cannabis addiction
Wenger, T., Moldrich, G., & Fürst, S. (2003) · Brain Research Bulletin · doi:10.1016/s0361-9230(03)00081-9 · Cited by 83
White, R., & Hiley, C. R. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702127 · Cited by 70
Differential cannabinoid-induced electrophysiological effects in rat ventral tegmentum
Cheer, J. F., Kendall, D. A., Mason, R., & Marsden, C. A. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00029-7 · Cited by 70
Cannabinoid-induced Fos expression within A10 dopaminergic neurons
Patel, S., & Hillard, C. J. (2003) · Brain Research · doi:10.1016/s0006-8993(02)03797-6 · Cited by 69
Romero, J., García‐Palomero, E., Lin, S., Ramos, J. A., Makriyannis, A., & Fernández‐Ruíz, J. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00086-0 · Cited by 59
Zhang, J., Chiodo, L. A., & Freeman, A. S. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38660-x · Cited by 58
Huang, C., Chen, Y.-L., Lo, S.-W., & Hsu, K. (2002) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12121-9 · Cited by 34
Wu, Y., Shen, K., & Johnson, S. W. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702680 · Cited by 31
Zheng, F., & Johnson, S. W. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00569-9 · Cited by 16
Cited by
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
“On the other hand, there is preclinical evidence to suggest that blockade of CB1 may be useful in the treatment of erectile dysfunction (Melis et al., 2004b, 2006).”
BackgroundEndocannabinoid-Mediated Control of Synaptic Transmission
Kano, M., Ohno-Shosaku, T., Hashimotodani, Y., Uchigashima, M., & Watanabe, M. (2009) · Physiological Reviews · doi:10.1152/physrev.00019.2008 · Cited by 1,529
Pierce, R. C., & Kumaresan, V. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.04.016 · Cited by 913
The Emerging Role of the Endocannabinoid System in Endocrine Regulation and Energy Balance
Pagotto, U., Marsicano, G., Cota, D., Lutz, B., & Pasquali, R. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0009 · Cited by 865
ENDOCANNABINOID-MEDIATED SYNAPTIC PLASTICITY IN THE CNS
Chevaleyre, V., Takahashi, K. A., & Castillo, P. E. (2006) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.29.051605.112834 · Cited by 783
Metadata
- Authors
- Melis, M., Pistis, M., Perra, S., Muntoni, A. L., Pillolla, G., & Gessa, G. L.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2004-01-07
- Volume
- 24
- Issue
- 1
- Pages
- 53-62
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2150821313
- Cited by
- 478
- References
- 94
- FWCI
- 17.40
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.